Several reports have demonstrated the upregulation of NAT1 in breast cancer is associated with estrogen receptor (ER) expression (Carlisle and Hein, 2018; Minchin and Butcher, 2018; Zhang et al., 2018). Here, NAT1 is linked to breast carcinoma.